APA (7th ed.) Citation

Krämer, I., Engelhardt, M., Fichtner, S., Neuber, B., Medenhoff, S., Bertsch, U., . . . Hundemer, M. (2016). Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro. OncoImmunology, 5(5), . https://doi.org/10.1080/2162402X.2016.1139662

Chicago Style (17th ed.) Citation

Krämer, Isabelle, et al. "Lenalidomide Enhances Myeloma-specific T-cell Responses in Vivo and in Vitro." OncoImmunology 5, no. 5 (2016). https://doi.org/10.1080/2162402X.2016.1139662.

MLA (9th ed.) Citation

Krämer, Isabelle, et al. "Lenalidomide Enhances Myeloma-specific T-cell Responses in Vivo and in Vitro." OncoImmunology, vol. 5, no. 5, 2016, https://doi.org/10.1080/2162402X.2016.1139662.